Study of Ociperlimab Plus Tislelizumab Plus Chemoradiotherapy in Participants With Untreated Limited-Stage Small Cell Lung Cancer
Completed · Phase 2
Conditions studied: Limited Stage Small Cell Lung Cancer
In brief
This phase 2 trial examined whether the preliminary efficacy and safety of ociperlimab, tislelizumab, and cCRT when used in combination is expected to advance treatment options in the serious unmet medical need population of Limited-Stage Small Cell Lung Cancer (LS-SCLC) participants .
Key facts
- Study ID
- NCT04952597
- Run by
- BeiGene
- People needed
- 126
- Starts
- 2021-07-15
- Expected to finish
- 2023-07-26
- Last updated by the study team
- 2024-10-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Tennessee Cancer Specialist — Knoxville, Tennessee, United States
- Peking University First Hospital — Beijing, Beijing Municipality, China
- Beijing Cancer Hospital — Beijing, Beijing Municipality, China
- Gansu Provincial Cancer Hospital — Lanzhou, Gansu, China
- The First Affiliated Hospital, Sun Yat Sen University — Guangzhou, Guangdong, China
- The Tumor Hospital Affiliated to Guangxi Medical University — Nanning, Guangxi, China
- Henan Cancer Hospital — Zhengzhou, Henan, China
- The First Affiliated Hospital of Zhengzhou University — Zhengzhou, Henan, China
- Union Hospital of Tongji Medical College, Huazhong University of Science and Technology — Wuhan, Hubei, China
- The Second Xiangya Hospital of Central South University — Changsha, Hunan, China
- Hunan Cancer Hospital — Changsha, Hunan, China
- Huai An First Peoples Hospital — Huaian, Jiangsu, China
- Nanjing Chest Hospital — Nanjing, Jiangsu, China
- The Affiliated Hospital of Xuzhou Medical University — Xuzhou, Jiangsu, China
- Hanzhong Central Hospital — Hanzhong, Shaanxi, China
- Qilu Hospital of Shandong University — Jinan, Shandong, China
- Linyi Cancer Hospital — Linyi, Shandong, China
- Qingdao Central Hospital — Qingdao, Shandong, China
- Yantai Yuhuangding Hospital — Yantai, Shandong, China
- Fudan University Shanghai Cancer Center — Shanghai, Shanghai Municipality, China
- Affiliated Zhongshan Hospital of Fudan University — Shanghai, Shanghai Municipality, China
- West China Hospital, Sichuan University — Chengdu, Sichuan, China
- Affiliated Hospital of North Sichuan Medical College — Nanchong, Sichuan, China
- Tianjin Medical University General Hospital — Tianjin, Tianjin Municipality, China
- Tianjin Medical University Cancer Institute and Hospital — Tianjin, Tianjin Municipality, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.